Skip to main content

NUVALENT, INC. insider trading

NUVL
$123.96Delayed · as of Jul 14, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Jul 14, 2026 to Jul 14, 2026. Price (+0.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • MSMatthew ShairDirector4.2982%of company
  • AAAndrew A. F. HackDirector1.9708%of company
  • JPJoseph PearlbergDirector0.007%of company
  • APAnna ProtopapasDirectorNot reportedof company
  • JRJames Richard PorterPresident and CEONot reportedof company
  • SSSapna SrivastavaDirectorNot reportedof company
  • DNDarlene NociChief Development OfficerNot reportedof company
  • ABAlexandra BalcomChief Financial OfficerNot reportedof company
  • HEHenry E. PelishChief Scientific OfficerNot reportedof company
  • DADeborah Ann MillerChief Legal OfficerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$261K-3.2%$123.81$261KJul 9, 2026Jul 10, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$1.37M-13.8%$100.16$1.37MMar 25, 2026Mar 26, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$170K-2.5%$99.71$170KMar 13, 2026Mar 16, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$257K-3.7%$98.83$257KMar 13, 2026Mar 16, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$78.7K-1.1%$97.89$78.7KMar 13, 2026Mar 16, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$18.6K-0.3%$98.40$18.6KJan 6, 2026Jan 7, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$133K-2.0%$97.33$133KJan 6, 2026Jan 7, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$107K-1.6%$96.75$107KJan 6, 2026Jan 7, 2026
NUVLDarlene NociChief Development OfficerOpen market sell$22.1K-0.6%$98.40$22.1KJan 6, 2026Jan 7, 2026
NUVLDarlene NociChief Development OfficerOpen market sell$159K-3.9%$97.33$159KJan 6, 2026Jan 7, 2026
NUVLDarlene NociChief Development OfficerOpen market sell$128K-3.0%$96.75$128KJan 6, 2026Jan 7, 2026
NUVLDeborah Ann MillerChief Legal OfficerOpen market sell$18K-0.4%$98.40$18KJan 6, 2026Jan 7, 2026
NUVLDeborah Ann MillerChief Legal OfficerOpen market sell$130K-3.1%$97.33$130KJan 6, 2026Jan 7, 2026
NUVLDeborah Ann MillerChief Legal OfficerOpen market sell$104K-2.4%$96.75$104KJan 6, 2026Jan 7, 2026
NUVLChristopher Durant TurnerChief Medical OfficerOpen market sell$22.1K-0.4%$98.40$22.1KJan 6, 2026Jan 7, 2026
NUVLChristopher Durant TurnerChief Medical OfficerOpen market sell$159K-2.9%$97.33$159KJan 6, 2026Jan 7, 2026
NUVLChristopher Durant TurnerChief Medical OfficerOpen market sell$128K-2.3%$96.75$128KJan 6, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$22.1K-0.3%$98.40$22.1KJan 6, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$159K-2.0%$97.33$159KJan 6, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$128K-1.6%$96.75$128KJan 6, 2026Jan 7, 2026
NUVLJames Richard PorterPresident and CEOOpen market sell$66.4K-0.2%$98.40$66.4KJan 6, 2026Jan 7, 2026
NUVLJames Richard PorterPresident and CEOOpen market sell$477K-1.7%$97.33$477KJan 6, 2026Jan 7, 2026
NUVLJames Richard PorterPresident and CEOOpen market sell$383K-1.4%$96.75$383KJan 6, 2026Jan 7, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$18.3K-0.3%$98.52$18.3KJan 5, 2026Jan 7, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$111K-1.6%$97.96$111KJan 5, 2026Jan 7, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$63.9K-0.9%$96.85$63.9KJan 5, 2026Jan 7, 2026
NUVLHenry E. PelishChief Scientific OfficerOpen market sell$49.3K-0.7%$96.06$49.3KJan 5, 2026Jan 7, 2026
NUVLDarlene NociChief Development OfficerOpen market sell$31.2K-0.7%$98.52$31.2KJan 5, 2026Jan 7, 2026
NUVLDarlene NociChief Development OfficerOpen market sell$189K-4.2%$97.96$189KJan 5, 2026Jan 7, 2026
NUVLDarlene NociChief Development OfficerOpen market sell$108K-2.4%$96.85$108KJan 5, 2026Jan 7, 2026
NUVLDarlene NociChief Development OfficerOpen market sell$83.7K-1.8%$96.06$83.7KJan 5, 2026Jan 7, 2026
NUVLDeborah Ann MillerChief Legal OfficerOpen market sell$32.1K-0.7%$98.52$32.1KJan 5, 2026Jan 7, 2026
NUVLDeborah Ann MillerChief Legal OfficerOpen market sell$195K-4.2%$97.96$195KJan 5, 2026Jan 7, 2026
NUVLDeborah Ann MillerChief Legal OfficerOpen market sell$112K-2.4%$96.85$112KJan 5, 2026Jan 7, 2026
NUVLDeborah Ann MillerChief Legal OfficerOpen market sell$86.2K-1.8%$96.06$86.2KJan 5, 2026Jan 7, 2026
NUVLChristopher Durant TurnerChief Medical OfficerOpen market sell$31.2K-0.5%$98.52$31.2KJan 5, 2026Jan 7, 2026
NUVLChristopher Durant TurnerChief Medical OfficerOpen market sell$189K-3.2%$97.96$189KJan 5, 2026Jan 7, 2026
NUVLChristopher Durant TurnerChief Medical OfficerOpen market sell$108K-1.8%$96.85$108KJan 5, 2026Jan 7, 2026
NUVLChristopher Durant TurnerChief Medical OfficerOpen market sell$83.7K-1.4%$96.06$83.7KJan 5, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$31.2K-0.4%$98.52$31.2KJan 5, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$189K-2.2%$97.96$189KJan 5, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$108K-1.3%$96.85$108KJan 5, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$83.7K-1.0%$96.06$83.7KJan 5, 2026Jan 7, 2026
NUVLJames Richard PorterPresident and CEOOpen market sell$132K-0.5%$98.52$132KJan 5, 2026Jan 7, 2026
NUVLJames Richard PorterPresident and CEOOpen market sell$798K-2.7%$97.96$798KJan 5, 2026Jan 7, 2026
NUVLJames Richard PorterPresident and CEOOpen market sell$458K-1.6%$96.85$458KJan 5, 2026Jan 7, 2026
NUVLJames Richard PorterPresident and CEOOpen market sell$353K-1.2%$96.06$353KJan 5, 2026Jan 7, 2026
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$11.1K-0.2%$111.32$11.1KDec 8, 2025Dec 10, 2025
NUVLAlexandra BalcomChief Financial OfficerOpen market sell$770K-11.3%$110.31$770KDec 8, 2025Dec 10, 2025
NUVLJames E. FlynnDirectorOpen market sell$35.4M-2.1%$95.45$35.4MNov 24, 2025Nov 24, 2025
50 of 63 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.